๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hormonal manipulation in the treatment of pancreatic carcinoma

โœ Scribed by B. A. Greenway


Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
137 KB
Volume
75
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

โœฆ Synopsis


Peptic ulcer surgery and colorectal cancer risk

Sir

We concur with the recently published paper by Toftgaard (Br J Surg 1987; 74: 573-5) and recent letter by Houghton and Mortensen (Br J Surg 1987; 74: 1066) that there is no statistically significant association between gastric surgery for benign peptic ulcer disease and the subsequent development of colorectal cancer (CRD). We examined, inter alia, the associations between previous surgery for benign peptic ulcer disease and CRC as part of a large, comprehensive, populationbased study of CRC incidence, aetiology and survival (The Melbourne Colorectal Cancer Study'). Previous peptic ulcer surgery was noted in 11 of 715 CRC cases and in 17 of 727 age and sex matched community


๐Ÿ“œ SIMILAR VOLUMES


Hormonal manipulation for pancreatic car
โœ M. C. Crowson; J. W. L. Fielding ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 143 KB ๐Ÿ‘ 1 views
Cost analysis of pancreatic carcinoma tr
โœ Wei Du; Daniel Touchette; Vainutis K. Vaitkevicius; William P. Peters; Anthony F ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 106 KB ๐Ÿ‘ 2 views
Ifosfamide is an inactive substance in t
โœ The Gastrointestinal Tumor Study Group ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 474 KB ๐Ÿ‘ 2 views

The Gastrointestinal Tumor Study Group (GITSG) investigated the efficacy of ifosfamide with mesna uroprotection in 30 patients with advanced inoperable pancreatic carcinoma that was confirmed histologically. All patients were required to have at least one bidimensional measurable lesion that could b

Bone fractures associated with luteinizi
โœ Murphy F. Townsend; W. Holt Sanders; Robert O. Northway; Sam D. Graham Jr. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 78 KB ๐Ÿ‘ 2 views

## Background: Luteinizing hormone-releasing hormone agonists (lhrh-a) have become an established treatment for certain patients with prostate carcinoma. lhrh-a are known to decrease bone mineral density. the purpose of this study was to determine the risk of bone fracture in men receiving lhrh-a f